➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Baxter
Johnson and Johnson
Moodys
AstraZeneca

Last Updated: June 2, 2020

DrugPatentWatch Database Preview

Jubilant Generics Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for JUBILANT GENERICS, and what generic and branded alternatives to JUBILANT GENERICS drugs are available?

JUBILANT GENERICS has thirty-nine approved drugs.



Summary for Jubilant Generics
US Patents:0
Tradenames:35
Ingredients:34
NDAs:39
Patent Litigation for Jubilant Generics: See patent lawsuits for Jubilant Generics

Drugs and US Patents for Jubilant Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics DARIFENACIN HYDROBROMIDE darifenacin hydrobromide TABLET, EXTENDED RELEASE;ORAL 205550-001 Oct 12, 2016 AB RX No No   Start Trial   Start Trial
Jubilant Generics NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 209156-003 May 14, 2018 AB RX No No   Start Trial   Start Trial
Jubilant Generics OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 200221-004 Sep 12, 2012 AB RX No No   Start Trial   Start Trial
Jubilant Generics TIZANIDINE HYDROCHLORIDE tizanidine hydrochloride CAPSULE;ORAL 209605-003 Aug 4, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Colorcon
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.